Hanson & Doremus Investment Management’s Athenahealth, Inc. ATHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-241
| Closed | -$32K | – | 478 |
|
|
2018
Q4 | $32K | Hold |
241
| – | – | 0.01% | 294 |
|
|
2018
Q3 | $32K | Hold |
241
| – | – | 0.01% | 326 |
|
|
2018
Q2 | $38K | Hold |
241
| – | – | 0.01% | 325 |
|
|
2018
Q1 | $34K | Sell |
241
-38
| -14% | -$5.19K | 0.01% | 348 |
|
|
2017
Q4 | $37K | Hold |
279
| – | – | 0.01% | 332 |
|
|
2017
Q3 | $35K | Sell |
279
-100
| -26% | -$13.8K | 0.01% | 320 |
|
|
2017
Q2 | $53K | Hold |
379
| – | – | 0.02% | 272 |
|
|
2017
Q1 | $43K | Hold |
379
| – | – | 0.02% | 281 |
|
|
2016
Q4 | $39.9K | Hold |
379
| – | – | 0.02% | 275 |
|
|
2016
Q3 | $48K | Sell |
379
-36
| -9% | -$4.58K | 0.02% | 252 |
|
|
2016
Q2 | $57K | Sell |
415
-85
| -17% | -$11.2K | 0.03% | 242 |
|
|
2016
Q1 | $69K | Hold |
500
| – | – | 0.03% | 228 |
|
|
2015
Q4 | $80K | Hold |
500
| – | – | 0.04% | 228 |
|
|
2015
Q3 | $67K | Sell |
500
-100
| -17% | -$13K | 0.03% | 233 |
|
|
2015
Q2 | $69K | Hold |
600
| – | – | 0.03% | 235 |
|
|
2015
Q1 | $72K | Sell |
600
-50
| -8% | -$6.66K | 0.03% | 234 |
|
|
2014
Q4 | $95K | Hold |
650
| – | – | 0.04% | 216 |
|
|
2014
Q3 | $86K | Hold |
650
| – | – | 0.04% | 223 |
|
|
2014
Q2 | $81K | Hold |
650
| – | – | 0.04% | 224 |
|
|
2014
Q1 | $104K | Sell |
650
-150
| -19% | -$24.7K | 0.05% | 206 |
|
|
2013
Q4 | $108K | Hold |
800
| – | – | 0.05% | 198 |
|
|
2013
Q3 | $87K | Hold |
800
| – | – | 0.04% | 208 |
|
|
2013
Q2 | $68K | Buy |
+800
| New | +$71.6K | 0.04% | 218 |
|
Hanson & Doremus Investment Management's ATHN Position: Q1 2019 in Review
Hanson & Doremus Investment Management sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 241 shares — an estimated $32K sold.
Hanson & Doremus Investment Management first reported a position in ATHN in Q2 2013 and held it in 23 quarters. The position peaked at $108K in Q4 2013. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.
- Hanson & Doremus Investment Management reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
- Hanson & Doremus Investment Management sold 241 Athenahealth, Inc. shares in Q1 2019, an estimated $32K.
- Hanson & Doremus Investment Management first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 23 quarters.
- Hanson & Doremus Investment Management's Athenahealth, Inc. position peaked at $108K in Q4 2013.
- 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.
Based on Hanson & Doremus Investment Management's 13F filing for Q1 2019, filed 23 Apr 2019.